Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000104

Chief Financial Officer sold 3,651 shares at $36.77 ($134,247)

  • Chief Financial Officer acquired 7,472 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-26 Exercise or conversion : show line 1 in the form 10b5-1 +7,472 37,521 D
2025-09-26 Sale : show line 2 in the form 10b5-1 −3,651 $36.77 $134,247 33,870 D
Open-market sales · 3,651 sh · avg $36.77 · $134,247

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-26 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −7,472 0 D
Loading xslF345X05/wk-form4_1759269358.xml…